ClinicalTrials.gov
public full text
Public Domain
The Effect of Xolair (Omalizumab) on Allergy Blood Cells
We are studying Xolair (omalizumab) to see it's effect on allergic blood cells. The blood tests will be done in a test tube to see if they react differently before and after treatment. The blood cells will be mixed with to whatever the person is allergic.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients#906848
- Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria#1126253
- Soluble CD23 Expression in Asthma Patients Treated With OMA#849103
- Product Development: Okra (Abelmoschus Esculentus) Chips with Localized Fish Powder#274252
- Omics Signature in the Diagnosis of Hypertension#852206
Record · ID 1044352
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive